Platelet C4d Is Associated With Acute Ischemic Stroke and Stroke Severity
- 1 December 2008
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 39 (12), 3236-3241
- https://doi.org/10.1161/strokeaha.108.514687
Abstract
Background and Purpose—Platelets bearing complement C4d were recently reported to be 99% specific for a diagnosis of systemic lupus erythematosus (SLE) and associated with neuropsychiatric lupus. We compared the prevalence of platelet C4d and investigated the clinical associations of platelet C4d in patients with acute ischemic stroke.Methods—We recruited 80 patients hospitalized for acute ischemic stroke. Stroke severity was measured by the National Institutes of Health Stroke Scale (NIH-SS). Infarct volume was determined by MRI. Platelet C4d was measured by flow cytometry.Results—Mean age was 57.9 years (range: 24.6 to 86.8 years), 58% were male, and 91% were white. Eight patients (10%) with acute ischemic stroke were platelet C4d-positive, which was significantly higher in prevalence compared to healthy controls (0%,PP=0.004). The median NIH-SS score and infarct volume for acute stroke patients were 6 (interquartile range [IQR]: 2 to 13) and 3.4 cc (IQR: 1.1 to 16.6), respectively. Platelet C4d-positive patients were more likely to have a severe stroke compared to those with negative platelet C4d (NIH-SS median: 17.5 versus 5,P=0.003). Positive platelet C4d was independently associated with stroke severity (P=0.03) after controlling for age, anticardiolipin antibody (aCL) status, and total anterior circulation of stroke involvement, and also with infarct volume (P=0.005) after controlling for age, aCL status, and old stroke by MRI.Conclusions—Platelet C4d is associated with severe acute ischemic stroke. Platelet C4d may be a biomarker as well as pathogenic clue that links cerebrovascular inflammation and thrombosis.Keywords
This publication has 17 references indexed in Scilit:
- Antagonistic effects of ultra-low-molecular-weight heparin against cerebral ischemia/reperfusion injury in ratsPharmacological Research, 2007
- Neuroprotective effect of pentosan polysulphate on ischemia-related neuronal death of the hippocampusNeuroscience Letters, 2006
- Complement Component C3 Mediates Inflammatory Injury Following Focal Cerebral IschemiaCirculation Research, 2006
- Platelet C4d is highly specific for systemic lupus erythematosusArthritis & Rheumatism, 2006
- The administration of cobra venom factor reduces post-ischemic cerebral injury in adult and neonatal ratsNeuroscience Letters, 2005
- Platelet activation leads to activation and propagation of the complement systemThe Journal of Experimental Medicine, 2005
- Systemic complement activation following human acute ischaemic strokeClinical and Experimental Immunology, 2004
- Antiphospholipid Antibodies and Stroke in Young WomenStroke, 2002
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993
- Classification and natural history of clinically identifiable subtypes of cerebral infarctionThe Lancet, 1991